2I0G

benzopyrans are selective estrogen receptor beta agonists (serbas) with novel activity in models of benign prostatic hyperplasia

• Total interactions analyzed: 1
• Total true interactions: 1
• Strongest Interaction:
  • Chains: A-B
  • Int. Res.: 154
  • Norm. En. per Res.: -2.2073
• Hub Node: A(1)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	-9.0073	66.9797	-397.891	-339.9186	154	26	10	16430	0	28	28

Interface residues

• A-B: ALA382A, ALA382B, ALA427A, ALA427B, ALA432A, ALA432B, ALA436A, ALA436B, ALA456A, ALA456B, ALA468A, ALA468B, ARG329A, ARG364A, ARG364B, ARG386A, ARG386B, ARG388A, ARG388B, ARG454A, ARG454B, ARG466A, ARG466B, ASN407A, ASN407B, ASN431A, ASN431B, ASN457A, ASN457B, ASN470A, ASN470B, ASN478A, ASN478B, ASP378A, ASP378B, ASP435A, ASP435B, GLN449A, GLN449B, GLN450A, GLN450B, GLN451A, GLN451B, GLU337A, GLU337B, GLU375A, GLU375B, GLU389A, GLU389B, GLU474A, GLU474B, GLY472A, GLY472B, HIS428A, HIS428B, HIS464A, HIS464B, HIS467A, HIS467B, HIS475A, HIS475B, ILE376A, ILE376B, ILE404A, ILE404B, ILE441A, LEU330A, LEU330B, LEU374A, LEU374B, LEU380A, LEU380B, LEU381A, LEU381B, LEU390A, LEU390B, LEU406A, LEU406B, LEU413A, LEU413B, LEU426A, LEU426B, LEU430A, LEU430B, LEU437A, LEU437B, LEU455A, LEU455B, LEU458A, LEU458B, LEU459A, LEU459B, LEU461A, LEU461B, LEU462A, LEU462B, LEU477A, LEU477B, LYS471A, LYS471B, MET336B, MET344A, MET379A, MET379B, MET403A, MET403B, MET410A, MET410B, MET453A, MET453B, MET460A, MET460B, MET473A, MET473B, PHE377A, PHE377B, PHE387A, PHE387B, PRO412A, PRO412B, SER333A, SER333B, SER385A, SER385B, SER408A, SER408B, SER409A, SER409B, SER423A, SER423B, SER448A, SER448B, SER452A, SER452B, SER463A, SER463B, SER469A, SER469B, THR383A, THR383B, THR384A, THR384B, THR434A, THR434B, TYR411A, TYR411B, VAL414A, VAL414B, VAL433A, VAL433B, VAL438A, VAL438B, VAL465A, VAL465B